| ²é¿´: 818 | »Ø¸´: 2 | |||
| ±¾Ìû²úÉú 1 ¸ö ·ÒëEPI £¬µã»÷ÕâÀï½øÐв鿴 | |||
[½»Á÷]
ÇóÒ»¶Î¼òÀú·Ò룬ӢÒëÖУ¬·Ç³£¸Ðл
|
|||
|
1£©Drove the programs to LI/LO/SoPD milestones/No Go decisions in a timely fashion 2£©Strong hands-on medchem experience and good track record in solving project related issues - e.g.,Lead ID (HTS screening, Lit-to-Lead, fragment-based, virtual screening), hit triaging and evaluation/profiling, SAR, potency, IP, DMPK (metabolic stability, solubility, protein binding, oral bioavailability, ivivc), PK/PD, tox (AMES, hERG, phospholipidosis), development of assay probes, biology tool compounds (benchmarking internal/external standards) |
» ²ÂÄãϲ»¶
22408 312Çóµ÷¼Á
ÒѾÓÐ17È˻ظ´
Ò»Ö¾Ô¸»ªÖÐũҵ071010£¬320Çóµ÷¼Á
ÒѾÓÐ6È˻ظ´
290µ÷¼ÁÉúÎï0860
ÒѾÓÐ41È˻ظ´
291Çóµ÷¼Á
ÒѾÓÐ3È˻ظ´
211±¾¿Æ²ÄÁÏ»¯¹¤Çóµ÷¼Á
ÒѾÓÐ23È˻ظ´
ɽ¶«Ê¡»ù½ð2026
ÒѾÓÐ9È˻ظ´
ҩѧÇóµ÷¼Á
ÒѾÓÐ13È˻ظ´
Çóµ÷¼ÁÍÆ¼ö
ÒѾÓÐ4È˻ظ´
085400µç×ÓÐÅÏ¢Àࣨ´¨´ó¿ØÖƹ¤³Ì£©Çóµ÷¼Á¿É¿çרҵ ÇóÀÏʦÁªÏµ
ÒѾÓÐ6È˻ظ´
²ÄÁϹ¤³Ì281»¹Óе÷¼Á»ú»áÂð
ÒѾÓÐ42È˻ظ´
» ÇÀ½ð±ÒÀ²£¡»ØÌû¾Í¿ÉÒԵõ½:
ÉúÎïÖÖµÄÑо¿
+2/2407
¼ÃÄÏ´óѧ-ÏȽø½¨Öþ²ÄÁϽÌÓý²¿¹¤³ÌÑо¿ÖÐÐÄ-´óÅ£ÍŶÓ-26½ì²©Ê¿ÉúÉêÇë
+1/186
ɽ¶«Õ÷Å®ÓÑ£¬×ø±ê¼ÃÄÏ
+1/178
°²»Õũҵ´óѧÀîÑǻԽÌÊÚÕÐÊÕ »¯Ñ§¡¢Å©Ò©Ñ§¡¢Ö²±£Àà2026¼¶²©Ê¿Ñо¿Éú
+3/105
¡ï¡ï±¬¡ï¡ïºÓ±±´óѧ·ÖÎö»¯Ñ§×¨Òµ£¬Ç¿ÊÆÑ§¿Æ£¬¼ñ©ÁË£¬0703»¯Ñ§¿¼Éú¾ù¿ÉÌµ÷¼Á
+1/87
³¤ÆÚÕÐÊÕ˶ʿѧÉú
+1/38
ÉúÎïÓëÒ½Ò©µ÷¼ÁÃû¶î¶à£¬×¨Òµ·¶Î§¿íʳƷÉúÎïÏà¹ØµÄ07£¬08£¬09£¬10¶¼¿Éµ÷
+1/37
ɽ¶«´óѧ¼¯³Éµç·ѧԺÕв©Ê¿ÁË
+1/16
Î人ÇṤ´óѧ»¯»·Ñ§Ôº£¨Ê¡ÖصãʵÑéÊÒ£©»¯Ñ§¹¤³ÌÓë¼¼Êõ£¨¹¤¡¢Àí¾ù¿É£©ÓÐÉÙÁ¿µ÷¼ÁÃû¶î
+1/10
ºÓÄÏũҵ´óѧÀíѧԺÕÐÊÕ»¯Ñ§£¨Ñ§Ë¶£©ºÍ²ÄÁÏÓ뻯¹¤£¨×¨Ë¶£©×¨ÒµË¶Ê¿µ÷¼ÁÉú2Ãû
+1/9
ºÓÄÏʦ´óÈ«¹úÖØµãʵÑéÊÒ¡ª0780ҩѧ¡¢08600ÉúÎïÓëÒ½Ò©ÈÔÓе÷¼ÁÖ¸±ê£¡
+1/9
½Î÷ʦ´ó»¯Ñ§¹¤³ÌѧԺµ÷¼Á½ñÍí0µã¿ª·Å£¡
+1/8
ºþÄÏÀí¹¤´óѧµ÷¼ÁϵͳÒÑ¿ª¡£ »¯Ñ§¡¢»¯¹¤¡¢²ÄÁÏ»¯¹¤ µ÷¼ÁÖ¸±ê³ä×㣬¼ȡÂʸߣ¬»¶Óµ÷¼Á
+1/8
ÆëÆë¹þ¶û´óѧÀîÀò¿ÎÌâ×é³ÏÕÐ2026¼¶¿¼Ñе÷¼ÁÉú£¨Ñ§Ë¶ºÍר˶£©
+1/5
ÑÓ°²´óѧ»¯Ñ§Ó뻯¹¤Ñ§Ôº½ÓÊÕµ÷¼ÁÉú£¨»¯Ñ§¡¢»¯¹¤Ñ§Ë¶ºÍ²ÄÁÏÓ뻯¹¤×¨Ë¶£©
+5/5
½Î÷Ë®ÀûµçÁ¦´óѧÊÐÕþ¹¤³Ì½ÓÊܵ÷¼Á
+1/4
Advanced Synthesis & Catalysis ¾ö¶¨ÊÇ·ñËÍÉóÒ»°ã¶à¾Ã£¿
+1/3
³¤°²´óѧÖÇÄܱ¬ÆÆ¿ÎÌâ×éÕÐÊÕ2026¼¶²©Ê¿ºÍ˶ʿÑо¿Éú
+1/2
È˹¤ÖÇÄÜÓë¼ÆË㻯ѧ½»²æÑо¿·½Ïò ½ÓÊܵ÷¼Á
+1/2
¾Å½Ñ§Ôº2026Äê˶ʿÑо¿Éúµ÷¼Á£¨086002ÖÆÒ©¹¤³Ì£©
+1/2
Õžü˧
ľ³æ (ÕýʽдÊÖ)
- ·ÒëEPI: 73
- Ó¦Öú: 0 (Ó×¶ùÔ°)
- ¹ó±ö: 0.005
- ½ð±Ò: 1037.1
- Ìû×Ó: 551
- ÔÚÏß: 79Сʱ
- ³æºÅ: 985303
cindyXia(½ð±Ò+1, ·ÒëEPI+1):°¥ Õâ¸öÊÇij¸öº£¹êµÄ¼òÀú£¬¾ÍÊÇÄǾäNo Go decisions in a timely fashion ²»ÖªËùÖ¸°¡ 2010-12-20 08:35:26
cindyXia(½ð±Ò+1): 2010-12-20 08:35:34
cindyXia(½ð±Ò+1): 2010-12-20 08:35:34
|
1£¬ÔÚLI/LO/SoPD ÏîÄ¿ÉÏÈ¡µÃǰËùδÓеijɼ¨¡££¨Â¥Ö÷µÚÒ»¶Î»°Ð´µÄÊDz»ÊÇÓÐÎÊÌâ°¡£¬°üÀ¨´óСд£¿£¿£© 2£¬ÓнÏÇ¿µÄ¶¯ÊÖÄÜÁ¦£¬²¢ÇÒÔÚ½â¾öÏîÄ¿ÓйØÎÊÌâÉÏÈ¡µÃÁ˽ϺõijɾÍ:ÈçLead ID (HTS¸ßͨÁ¿É¸Ñ¡£¬ÒÔÆ¬¶ÎΪ»ù´¡£¬ÐéÄâɸѡµÈ£©¡£¹¹Ð§¹ØÏµ£¬Ð§ÄÜ£¬IP,Ò©´ú¶¯Á¦Ñ§£¬PK/PD,¶¾ÐÔ£¨°£Ä·Ë¹ÊÏʵÑ飬HERG,Á×Ö¬Öʲ¡£©£¬¼ì²â̽ÕëµÄ¿ª·¢£¬ÉúÎ﹤¾ß¸´ºÏÎïµÈ¡£ |
2Â¥2010-12-18 15:41:24
Õžü˧
ľ³æ (ÕýʽдÊÖ)
- ·ÒëEPI: 73
- Ó¦Öú: 0 (Ó×¶ùÔ°)
- ¹ó±ö: 0.005
- ½ð±Ò: 1037.1
- Ìû×Ó: 551
- ÔÚÏß: 79Сʱ
- ³æºÅ: 985303
3Â¥2010-12-20 09:15:27














»Ø¸´´ËÂ¥